Aberrant expression profiles of miRNAs are widely observed in the clinical tissue specimens
and urine samples as well as the blood samples of bladder cancer patients. These profiles …

Although gene fusions occur rarely in non-small-cell lung cancer (NSCLC) patients, they
represent a relevant target in treatment decision algorithms. To date, immunohistochemistry …

BACKGROUND Ovarian serous carcinoma (OSC) is a fatal gynecologic malignancy usually
presenting with bilateral localization and malignant peritoneal effusion. Programmed cell …

Aims Laryngeal squamous cell carcinoma (LSCC) prognosis is definitely related to lymph
node metastasis. Epithelial–mesenchymal transition (EMT) allows neoplastic cells to gain …

BACKGROUND In pleural effusion cytology, the distinction of malignant mesothelioma (MM)
from reactive mesothelial cells (RMCs) may be challenging, even with the aid of …

Sorafenib represents the first effective targeted therapy for advanced stage hepatocellular
carcinoma (HCC); however, adequate patient stratification regarding sorafenib …

This study presents a critical appraisal of previously published study data of miRNAs in
blood, urine and exosomes as biomarkers of bladder cancer (BC). The evaluation included …

Aside from its diagnostic importance, urinary tract endoscopy is an uncomfortable,
expensive, and time-consuming procedure. Patients with a history of urothelial carcinoma …

Objectives This study aimed to develop reliable biomarkers that improve the ability of bile
cytology to diagnose cholangiocarcinoma vs benign biliary lesions. Methods Many studies …

Bladder cancer is the most common malignant tumor of the urinary system, and it has high
incidence, high degree of malignancy, and easy recurrence after surgery. The etiology and …